Sleep practitioners need to be aware of new changes in the labeling of pemoline (CYLERT)
Littner
M
M
D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D001364:Awareness; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D006970:Disorders of Excessive Somnolence / Q000188:drug therapy*; D004348:Drug Labeling; D006282:Health Personnel; D006801:Humans; D009290:Narcolepsy / Q000188:drug therapy*; D010389:Pemoline / Q000627:therapeutic use*
D000697:Central Nervous System Stimulants; D010389:Pemoline